Found 43 Enz. Inhib. hit(s) with all data for entry = 8187 TargetCannabinoid receptor 1(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 2.94nM ΔG°: -49.5kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 6nM ΔG°: -47.7kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 14nM ΔG°: -45.6kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 56.8nM ΔG°: -42.0kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 77.1nM ΔG°: -41.3kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 81.5nM ΔG°: -41.1kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 84.6nM ΔG°: -41.0kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 106nM ΔG°: -40.5kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 168nM ΔG°: -39.3kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 230nM ΔG°: -38.5kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 704nM ΔG°: -35.7kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 1.15E+3nM ΔG°: -34.5kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 1.27E+3nM ΔG°: -34.2kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 1.37E+3nM ΔG°: -34.0kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 1.50E+3nM ΔG°: -33.8kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 1.72E+3nM ΔG°: -33.5kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 2.51E+3nM ΔG°: -32.5kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 6.46E+3nM ΔG°: -30.1kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 7.91E+3nM ΔG°: -29.6kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: >1.00E+4nM ΔG°: >-29.0kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: >1.00E+4nM ΔG°: >-29.0kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataKi: 1.17E+4nM ΔG°: -28.6kJ/molepH: 7.4 T: 2°CAssay Description:The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataIC50: 117nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataIC50: 162nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataIC50: 239nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataIC50: 313nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataIC50: 321nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataIC50: 330nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataIC50: 385nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataIC50: 425nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataIC50: 925nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataIC50: 1.15E+3nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataIC50: 1.53E+3nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataIC50: 2.09E+3nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataIC50: 2.29E+3nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataIC50: 3.37E+3nMpH: 7.5 T: 2°CAssay Description:Cells were seeded at a density of 10,000 cells per well in poly-L-lysine treated 96-well culture plates (BD Biosciences). The following day wells wer...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataEC50: 26.4nMpH: 7.5Assay Description:Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataEC50: 344nMpH: 7.5Assay Description:Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataEC50: 185nMpH: 7.5Assay Description:Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataEC50: 577nMpH: 7.5Assay Description:Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataEC50: 136nMpH: 7.5Assay Description:Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataEC50: 18.3nMpH: 7.5Assay Description:Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Yissum Research Development Company Of The Hebrew University Of Jerusalem
US Patent
Affinity DataEC50: 126nMpH: 7.5Assay Description:Human CB2 expressing CHO-K1 membranes (5 μg per incubation mixture) were diluted in 50 mM Tris-HCl (pH 7.5) and 0.5 mM EDTA and added to HU comp...More data for this Ligand-Target Pair
